HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Coordinated expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 and heme oxygenase 2: evidence for a regulatory link between glycolysis and heme catabolism.

Abstract
Heme is an essential requirement for cell survival. Heme oxygenase (HO) is the rate-limiting enzyme in heme catabolism and consists of two isozymes, HO-1 and HO-2. To identify the protein that regulates the expression or function of HO-1 or HO-2, we searched for proteins that interact with both isozymes, using protein microarrays. We thus identified 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) that synthesizes or degrades fructose-2,6-bisphosphate, a key activator of glycolysis, depending on cellular microenvironments. Importantly, HO-2 and PFKFB4 are predominantly expressed in haploid spermatids. Here, we show a drastic reduction in expression levels of PFKFB4 mRNA and protein and HO-2 mRNA in HepG2 human hepatoma cells in responses to glucose deprivation (≤ 2.5 mM), which occurred concurrently with remarkable induction of HO-1 mRNA and protein. Knockdown of HO-2 expression in HepG2 cells, using small interfering RNA, caused PFKFB4 mRNA levels to decrease with a concurrent increase in HO-1 expression. Thus, in HepG2 cells, HO-1 expression was increased, when expression levels of HO-2 and PFKFB4 mRNAs were decreased. Conversely, overexpression of HO-2 in HepG2 cells caused the level of co-expressed PFKFB4 protein to increase. These results suggest a potential regulatory role for HO-2 in ensuring PFKFB4 expression. Moreover, in D407 human retinal pigment epithelial cells, glucose deprivation decreased the expression levels of PFKFB4, HO-1, and HO-2 mRNAs. Thus, glucose deprivation consistently down-regulated the expression of PFKFB4 and HO-2 mRNAs in both HepG2 cells and RPE cells. We therefore postulate that PFKFB4 and HO-2 are expressed in a coordinated manner to maintain glucose homeostasis.
AuthorsBin Li, Kazuhisa Takeda, Kazunobu Ishikawa, Miki Yoshizawa, Michihiko Sato, Shigeki Shibahara, Kazumichi Furuyama
JournalThe Tohoku journal of experimental medicine (Tohoku J Exp Med) Vol. 228 Issue 1 Pg. 27-41 (09 2012) ISSN: 1349-3329 [Electronic] Japan
PMID22892400 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • PFKFB4 protein, human
  • RNA, Messenger
  • Heme
  • Heme Oxygenase (Decyclizing)
  • Heme Oxygenase-1
  • heme oxygenase-2
  • Phosphofructokinase-2
  • Glucose
Topics
  • Animals
  • Down-Regulation (genetics)
  • Epithelial Cells (enzymology)
  • Gene Expression Regulation, Enzymologic
  • Gene Knockdown Techniques
  • Glucose (deficiency)
  • Glycolysis (genetics)
  • HeLa Cells
  • Heme (metabolism)
  • Heme Oxygenase (Decyclizing) (deficiency, genetics, metabolism)
  • Heme Oxygenase-1 (genetics, metabolism)
  • Hep G2 Cells
  • Humans
  • Liver (enzymology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Models, Biological
  • Organ Specificity
  • Phosphofructokinase-2 (genetics, metabolism)
  • Protein Array Analysis
  • Protein Binding
  • RNA, Messenger (genetics, metabolism)
  • Testis (enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: